Related Experiment Videos
Ablation therapy for cardiac arrhythmias
W G Stevenson1, K E Ellison, D C Lefroy
1Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
The American Journal of Cardiology
|November 14, 1997
Summary
Catheter ablation is a highly effective treatment for many tachyarrhythmias, including Wolff-Parkinson-White syndrome and atrioventricular nodal reentry. While effective for atrial flutter and some ventricular tachycardias, further research is needed for atrial fibrillation and complex ventricular arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Technology
Background:
- Ablation therapy is increasingly utilized for tachyarrhythmias.
- Surgical ablation initially demonstrated feasibility, but catheter ablation is now the predominant approach.
- Various tachyarrhythmias are targets for ablation, with differing success rates.
Purpose of the Study:
- To review the efficacy of catheter and surgical ablation for different types of tachyarrhythmias.
- To highlight the current status and future directions of ablation technologies in arrhythmia management.
Main Methods:
- Review of existing literature on surgical and catheter ablation techniques for tachyarrhythmias.
- Analysis of efficacy data for specific arrhythmias like Wolff-Parkinson-White syndrome, atrial flutter, atrial fibrillation, and ventricular tachycardia.
Main Results:
- Catheter ablation is highly effective for Wolff-Parkinson-White syndrome, atrioventricular nodal reentry, and atrial ectopic tachycardia.
- Catheter ablation is effective for atrial flutter, though many patients still require therapy for atrial fibrillation.
- Efficacy of ablation for ventricular tachycardia varies; catheter ablation is effective for idiopathic and bundle-branch reentry VT, while surgical ablation is an option for specific post-MI VT.
- Catheter ablation shows promise for VT in selected patients with advances in mapping technology.
Conclusions:
- Catheter ablation is a primary treatment for many tachyarrhythmias.
- Further definition of risks and long-term efficacy is needed for catheter ablation maze procedures for atrial fibrillation.
- Advancements in mapping and ablation technology will expand nonpharmacologic control of cardiac arrhythmias.